Matthew E. Korenberg, President & COO at LIGAND PHARMACEUTICALS INC (LGND), sold 36,490 shares at $98.50 ($3.6M) on 2024-08-09, disclosed to the SEC on 2024-08-13.
Open-market sale of $3.6M LGND by President & COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.50 | 18,245 | $1.8M | 50.0% |
| 2 | $98.50 | 18,245 | $1.8M | 50.0% |
| Total | $98.50 avg | 36,490 | $3.6M | 100% |
| Filing → |
| LGND | SELL | 2024-05-15 | $2.9M | — | Filing → |
| LGND | BUY | 2019-09-03 | $43K | — | Filing → |
| LGND | SELL | 2018-08-29 | $9.4M | — | Filing → |